气味汗症治疗的全球市场:2022年~2026年
市场调查报告书
商品编码
1090263

气味汗症治疗的全球市场:2022年~2026年

Global Bromhidrosis Disease Treatment Market 2022-2026

出版日期: | 出版商: TechNavio | 英文 120 Pages | 订单完成后即时交付

价格

全球气味汗症治疗的市场规模在2022年~2026年间,预测将成长到3亿6,276万美元,在预测期间内预计将以8.92%的年复合成长率增长。

市场成长的主要因素有糖尿病和肾臟病的患者数增加,政府对疾病的认识计划的增加以及美国医疗保健成本的普遍下降等。

本报告涵括气味汗症治疗的全球市场的整体分析,提供市场规模与预测,趋势,成长促进因素,课题,及约25供应商的分析。

目录

第1章 摘要整理

  • 市场概要

第2章 市场形势

  • 市场生态系统

第3章 市场规模

  • 市场定义
  • 市场区隔分析
  • 2021年的市场规模
  • 市场预测:从2021年~2026年的预测

第4章 波特的五力分析

  • 五力彙整
  • 买方议价能力
  • 供给企业谈判力
  • 新加入厂商业者的威胁
  • 替代品的威胁
  • 竞争的威胁
  • 市场情况

第5章 市场区隔:各类型

  • 市场区隔
  • 各类型的比较
  • 大汗腺体臭:市场规模与预测(2021年~2026年)
  • 外泌体体味:市场规模与预测(2021年~2026年)
  • 各类型的市场机会

第6章 客户形势

  • 客户形势概要

第7章 各地区形势

  • 各地区市场区隔
  • 各地区的比较
  • 北美:市场规模与预测(2021年~2026年)
  • 欧洲:市场规模与预测(2021年~2026年)
  • 亚洲:市场规模与预测(2021年~2026年)
  • 其他地区:市场规模与预测(2021年~2026年)
  • 美国:市场规模与预测(2021年~2026年)
  • 加拿大:市场规模与预测(2021年~2026年)
  • 德国:市场规模与预测(2021年~2026年)
  • 中国:市场规模与预测(2021年~2026年)
  • 英国:市场规模与预测(2021年~2026年)
  • 各地区形势的市场机会

第8章 推动要素,课题,及趋势

  • 市场推动要素
  • 市场课题
  • 推动要素与课题的影响
  • 市场趋势

第9章 业者情势

  • 概要
  • 业者情势
  • 混乱状况
  • 产业的风险

第10章 供应商分析

  • 交易厂商
  • 供应商的市场定位
  • AbbVie Inc.
  • Boehringer Ingelheim International GmbH
  • Galderma SA
  • Hikma Pharmaceuticals Plc
  • Ipsen Pharma
  • Johnson and Johnson
  • Medytox Inc.
  • Merz Pharma GmbH and Co. KGaA
  • Novartis AG
  • Pfizer Inc.

第11章 附录

Product Code: IRTNTR73696

Technavio has been monitoring the bromhidrosis disease treatment market and it is poised to grow by $ 362.76 million during 2022-2026, accelerating at a CAGR of 8.92% during the forecast period. Our report on the bromhidrosis disease treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising in the number of patients affected by diabetes and kidney diseases, a rise in government awareness programs about the disease, and a rise in healthcare affordability in the US.

The bromhidrosis disease treatment market analysis includes type segment and geographic landscape.

Technavio's bromhidrosis disease treatment market is segmented as below:

By Type

  • Apocrine body odor
  • Eccrine body odor

By Geographical Landscape

  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the increasing number of m and a by vendors as one of the prime reasons driving the bromhidrosis disease treatment market growth during the next few years. Also, a rise in the r and d activities and an increase in the technological advancements and modernization in the healthcare sector will lead to sizable demand in the market.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters. Our report on the bromhidrosis disease treatment market covers the following areas:

  • Bromhidrosis disease treatment market sizing
  • Bromhidrosis disease treatment market forecast
  • Bromhidrosis disease treatment market industry analysis

Technavio's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading bromhidrosis disease treatment market vendors that include AbbVie Inc., Biovencer Healthcare Pvt. Ltd., Boehringer Ingelheim International GmbH, Galderma SA, Hikma Pharmaceuticals Plc, Ipsen Pharma, Johnson and Johnson, Journey Medical Corp., Medytox Inc., Merz Pharma GmbH and Co. KGaA, Novartis AG, and Pfizer Inc. Also, the bromhidrosis disease treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

Technavio presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. Technavio's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

  • 1.1 Market overview
  • Exhibit 01: Executive Summary - Chart on Market Overview
  • Exhibit 02: Executive Summary - Data Table on Market Overview
  • Exhibit 03: Executive Summary - Chart on Global Market Characteristics
  • Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibit 05: Executive Summary - Chart on Market Segmentation by Type
  • Exhibit 06: Executive Summary - Chart on Incremental Growth
  • Exhibit 07: Executive Summary - Data Table on Incremental Growth
  • Exhibit 08: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
  • Exhibit 09: Parent market
  • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
  • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
  • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026
  • Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary
  • Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers
  • Exhibit 18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers
  • Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants
  • Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes
  • Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry
  • Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • 4.7 Market condition
  • Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Type

  • 5.1 Market segments
  • Exhibit 24: Chart on Type - Market share 2021-2026 (%)
  • Exhibit 25: Data Table on Type - Market share 2021-2026 (%)
  • 5.2 Comparison by Type
  • Exhibit 26: Chart on Comparison by Type
  • Exhibit 27: Data Table on Comparison by Type
  • 5.3 Apocrine body odor - Market size and forecast 2021-2026
  • Exhibit 28: Chart on Apocrine body odor - Market size and forecast 2021-2026 ($ million)
  • Exhibit 29: Data Table on Apocrine body odor - Market size and forecast 2021-2026 ($ million)
  • Exhibit 30: Chart on Apocrine body odor - Year-over-year growth 2021-2026 (%)
  • Exhibit 31: Data Table on Apocrine body odor - Year-over-year growth 2021-2026 (%)
  • 5.4 Eccrine body odor - Market size and forecast 2021-2026
  • Exhibit 32: Chart on Eccrine body odor - Market size and forecast 2021-2026 ($ million)
  • Exhibit 33: Data Table on Eccrine body odor - Market size and forecast 2021-2026 ($ million)
  • Exhibit 34: Chart on Eccrine body odor - Year-over-year growth 2021-2026 (%)
  • Exhibit 35: Data Table on Eccrine body odor - Year-over-year growth 2021-2026 (%)
  • 5.5 Market opportunity by Type
  • Exhibit 36: Market opportunity by Type ($ million)

6 Customer Landscape

  • 6.1 Customer landscape overview
  • Exhibit 37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation
  • Exhibit 38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibit 39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • 7.2 Geographic comparison
  • Exhibit 40: Chart on Geographic comparison
  • Exhibit 41: Data Table on Geographic comparison
  • 7.3 North America - Market size and forecast 2021-2026
  • Exhibit 42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibit 44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibit 45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • 7.4 Europe - Market size and forecast 2021-2026
  • Exhibit 46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibit 48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibit 49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • 7.5 Asia - Market size and forecast 2021-2026
  • Exhibit 50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibit 52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibit 53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
  • Exhibit 54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibit 56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibit 57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • 7.7 US - Market size and forecast 2021-2026
  • Exhibit 58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibit 60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibit 61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • 7.8 Canada - Market size and forecast 2021-2026
  • Exhibit 62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibit 64: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibit 65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • 7.9 Germany - Market size and forecast 2021-2026
  • Exhibit 66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibit 68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibit 69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • 7.10 China - Market size and forecast 2021-2026
  • Exhibit 70: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 71: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibit 72: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibit 73: Data Table on China - Year-over-year growth 2021-2026 (%)
  • 7.11 UK - Market size and forecast 2021-2026
  • Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity By Geographical Landscape
  • Exhibit 78: Market opportunity By Geographical Landscape ($ million)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges
  • Exhibit 79: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape
  • Exhibit 80: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption
  • Exhibit 81: Overview on factors of disruption
  • 9.4 Industry risks
  • Exhibit 82: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered
  • Exhibit 83: Vendors covered
  • 10.2 Market positioning of vendors
  • Exhibit 84: Matrix on vendor position and classification
  • 10.3 AbbVie Inc.
  • Exhibit 85: AbbVie Inc. - Overview
  • Exhibit 86: AbbVie Inc. - Product / Service
  • Exhibit 87: AbbVie Inc. - Key offerings
  • 10.4 Boehringer Ingelheim International GmbH
  • Exhibit 88: Boehringer Ingelheim International GmbH - Overview
  • Exhibit 89: Boehringer Ingelheim International GmbH - Business segments
  • Exhibit 90: Boehringer Ingelheim International GmbH - Key news
  • Exhibit 91: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibit 92: Boehringer Ingelheim International GmbH - Segment focus
  • 10.5 Galderma SA
  • Exhibit 93: Galderma SA - Overview
  • Exhibit 94: Galderma SA - Product / Service
  • Exhibit 95: Galderma SA - Key news
  • Exhibit 96: Galderma SA - Key offerings
  • 10.6 Hikma Pharmaceuticals Plc
  • Exhibit 97: Hikma Pharmaceuticals Plc - Overview
  • Exhibit 98: Hikma Pharmaceuticals Plc - Business segments
  • Exhibit 99: Hikma Pharmaceuticals Plc - Key offerings
  • Exhibit 100: Hikma Pharmaceuticals Plc - Segment focus
  • 10.7 Ipsen Pharma
  • Exhibit 101: Ipsen Pharma - Overview
  • Exhibit 102: Ipsen Pharma - Business segments
  • Exhibit 103: Ipsen Pharma - Key offerings
  • Exhibit 104: Ipsen Pharma - Segment focus
  • 10.8 Johnson and Johnson
  • Exhibit 105: Johnson and Johnson - Overview
  • Exhibit 106: Johnson and Johnson - Business segments
  • Exhibit 107: Johnson and Johnson - Key news
  • Exhibit 108: Johnson and Johnson - Key offerings
  • Exhibit 109: Johnson and Johnson - Segment focus
  • 10.9 Medytox Inc.
  • Exhibit 110: Medytox Inc. - Overview
  • Exhibit 111: Medytox Inc. - Product / Service
  • Exhibit 112: Medytox Inc. - Key offerings
  • 10.10 Merz Pharma GmbH and Co. KGaA
  • Exhibit 113: Merz Pharma GmbH and Co. KGaA - Overview
  • Exhibit 114: Merz Pharma GmbH and Co. KGaA - Product / Service
  • Exhibit 115: Merz Pharma GmbH and Co. KGaA - Key offerings
  • 10.11 Novartis AG
  • Exhibit 116: Novartis AG - Overview
  • Exhibit 117: Novartis AG - Business segments
  • Exhibit 118: Novartis AG - Key offerings
  • Exhibit 119: Novartis AG - Segment focus
  • 10.12 Pfizer Inc.
  • Exhibit 120: Pfizer Inc. - Overview
  • Exhibit 121: Pfizer Inc. - Product / Service
  • Exhibit 122: Pfizer Inc. - Key news
  • Exhibit 123: Pfizer Inc. - Key offerings

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist
  • Exhibit 124: Inclusions checklist
  • Exhibit 125: Exclusions checklist
  • 11.3 Currency conversion rates for US$
  • Exhibit 126: Currency conversion rates for US$
  • 11.4 Research methodology
  • Exhibit 127: Research methodology
  • Exhibit 128: Validation techniques employed for market sizing
  • Exhibit 129: Information sources
  • 11.5 List of abbreviations
  • Exhibit 130: List of abbreviations

Exhibits:

  • Exhibits1: Executive Summary - Chart on Market Overview
  • Exhibits2: Executive Summary - Data Table on Market Overview
  • Exhibits3: Executive Summary - Chart on Global Market Characteristics
  • Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
  • Exhibits5: Executive Summary - Chart on Market Segmentation by Type
  • Exhibits6: Executive Summary - Chart on Incremental Growth
  • Exhibits7: Executive Summary - Data Table on Incremental Growth
  • Exhibits8: Executive Summary - Chart on Vendor Market Positioning
  • Exhibits9: Parent market
  • Exhibits10: Market Characteristics
  • Exhibits11: Offerings of vendors included in the market definition
  • Exhibits12: Market segments
  • Exhibits13: Chart on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
  • Exhibits15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
  • Exhibits17: Five forces analysis - Comparison between 2021 and 2026
  • Exhibits18: Chart on Bargaining power of buyers - Impact of key factors 2021 and 2026
  • Exhibits19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
  • Exhibits20: Threat of new entrants - Impact of key factors in 2021 and 2026
  • Exhibits21: Threat of substitutes - Impact of key factors in 2021 and 2026
  • Exhibits22: Threat of rivalry - Impact of key factors in 2021 and 2026
  • Exhibits23: Chart on Market condition - Five forces 2021 and 2026
  • Exhibits24: Chart on Type - Market share 2021-2026 (%)
  • Exhibits25: Data Table on Type - Market share 2021-2026 (%)
  • Exhibits26: Chart on Comparison by Type
  • Exhibits27: Data Table on Comparison by Type
  • Exhibits28: Chart on Apocrine body odor - Market size and forecast 2021-2026 ($ million)
  • Exhibits29: Data Table on Apocrine body odor - Market size and forecast 2021-2026 ($ million)
  • Exhibits30: Chart on Apocrine body odor - Year-over-year growth 2021-2026 (%)
  • Exhibits31: Data Table on Apocrine body odor - Year-over-year growth 2021-2026 (%)
  • Exhibits32: Chart on Eccrine body odor - Market size and forecast 2021-2026 ($ million)
  • Exhibits33: Data Table on Eccrine body odor - Market size and forecast 2021-2026 ($ million)
  • Exhibits34: Chart on Eccrine body odor - Year-over-year growth 2021-2026 (%)
  • Exhibits35: Data Table on Eccrine body odor - Year-over-year growth 2021-2026 (%)
  • Exhibits36: Market opportunity by Type ($ million)
  • Exhibits37: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Exhibits38: Chart on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits39: Data Table on Market share By Geographical Landscape 2021-2026 (%)
  • Exhibits40: Chart on Geographic comparison
  • Exhibits41: Data Table on Geographic comparison
  • Exhibits42: Chart on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits43: Data Table on North America - Market size and forecast 2021-2026 ($ million)
  • Exhibits44: Chart on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits45: Data Table on North America - Year-over-year growth 2021-2026 (%)
  • Exhibits46: Chart on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits47: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
  • Exhibits48: Chart on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits49: Data Table on Europe - Year-over-year growth 2021-2026 (%)
  • Exhibits50: Chart on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits51: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
  • Exhibits52: Chart on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits53: Data Table on Asia - Year-over-year growth 2021-2026 (%)
  • Exhibits54: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits55: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
  • Exhibits56: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits57: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
  • Exhibits58: Chart on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits59: Data Table on US - Market size and forecast 2021-2026 ($ million)
  • Exhibits60: Chart on US - Year-over-year growth 2021-2026 (%)
  • Exhibits61: Data Table on US - Year-over-year growth 2021-2026 (%)
  • Exhibits62: Chart on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits63: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
  • Exhibits64: Chart on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits65: Data Table on Canada - Year-over-year growth 2021-2026 (%)
  • Exhibits66: Chart on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits67: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
  • Exhibits68: Chart on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits69: Data Table on Germany - Year-over-year growth 2021-2026 (%)
  • Exhibits70: Chart on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits71: Data Table on China - Market size and forecast 2021-2026 ($ million)
  • Exhibits72: Chart on China - Year-over-year growth 2021-2026 (%)
  • Exhibits73: Data Table on China - Year-over-year growth 2021-2026 (%)
  • Exhibits74: Chart on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
  • Exhibits76: Chart on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits77: Data Table on UK - Year-over-year growth 2021-2026 (%)
  • Exhibits78: Market opportunity By Geographical Landscape ($ million)
  • Exhibits79: Impact of drivers and challenges in 2021 and 2026
  • Exhibits80: Overview on Criticality of inputs and Factors of differentiation
  • Exhibits81: Overview on factors of disruption
  • Exhibits82: Impact of key risks on business
  • Exhibits83: Vendors covered
  • Exhibits84: Matrix on vendor position and classification
  • Exhibits85: AbbVie Inc. - Overview
  • Exhibits86: AbbVie Inc. - Product / Service
  • Exhibits87: AbbVie Inc. - Key offerings
  • Exhibits88: Boehringer Ingelheim International GmbH - Overview
  • Exhibits89: Boehringer Ingelheim International GmbH - Business segments
  • Exhibits90: Boehringer Ingelheim International GmbH - Key news
  • Exhibits91: Boehringer Ingelheim International GmbH - Key offerings
  • Exhibits92: Boehringer Ingelheim International GmbH - Segment focus
  • Exhibits93: Galderma SA - Overview
  • Exhibits94: Galderma SA - Product / Service
  • Exhibits95: Galderma SA - Key news
  • Exhibits96: Galderma SA - Key offerings
  • Exhibits97: Hikma Pharmaceuticals Plc - Overview
  • Exhibits98: Hikma Pharmaceuticals Plc - Business segments
  • Exhibits99: Hikma Pharmaceuticals Plc - Key offerings
  • Exhibits100: Hikma Pharmaceuticals Plc - Segment focus
  • Exhibits101: Ipsen Pharma - Overview
  • Exhibits102: Ipsen Pharma - Business segments
  • Exhibits103: Ipsen Pharma - Key offerings
  • Exhibits104: Ipsen Pharma - Segment focus
  • Exhibits105: Johnson and Johnson - Overview
  • Exhibits106: Johnson and Johnson - Business segments
  • Exhibits107: Johnson and Johnson - Key news
  • Exhibits108: Johnson and Johnson - Key offerings
  • Exhibits109: Johnson and Johnson - Segment focus
  • Exhibits110: Medytox Inc. - Overview
  • Exhibits111: Medytox Inc. - Product / Service
  • Exhibits112: Medytox Inc. - Key offerings
  • Exhibits113: Merz Pharma GmbH and Co. KGaA - Overview
  • Exhibits114: Merz Pharma GmbH and Co. KGaA - Product / Service
  • Exhibits115: Merz Pharma GmbH and Co. KGaA - Key offerings
  • Exhibits116: Novartis AG - Overview
  • Exhibits117: Novartis AG - Business segments
  • Exhibits118: Novartis AG - Key offerings
  • Exhibits119: Novartis AG - Segment focus
  • Exhibits120: Pfizer Inc. - Overview
  • Exhibits121: Pfizer Inc. - Product / Service
  • Exhibits122: Pfizer Inc. - Key news
  • Exhibits123: Pfizer Inc. - Key offerings
  • Exhibits124: Inclusions checklist
  • Exhibits125: Exclusions checklist
  • Exhibits126: Currency conversion rates for US$
  • Exhibits127: Research methodology
  • Exhibits128: Validation techniques employed for market sizing
  • Exhibits129: Information sources
  • Exhibits130: List of abbreviations